Trust before intelligence: Preparing Biopharma for an AI era

Discover why biopharma companies must structure data, classify sensitive content, and establish governance before deploying AI to avoid costly compliance risks.

The biopharma companies extracting real value from AI are not the ones that moved fastest. They’re the ones that moved in the right order.

Before activating any AI capability, the most successful organisations structured their document environment, classified sensitive information, and established governance. That sequencing — structure, classify, govern, then AI — is what separates productive AI from expensive, compliance-exposing chaos.

The unstructured data problem

Phase III clinical trials now average nearly six million data points, and AI adoption across life sciences has risen sharply. Yet the document-heavy workflows that underpin clinical operations remain largely untouched.

The reason is straightforward: Roughly 90% of all content generated across the R&D function is unstructured. Investigator CVs, site feasibility questionnaires, clinical protocols, financial disclosure forms, and patient summaries all contain critical information, but it can’t be systematically queried or fed reliably into AI workflows. Study startup alone can take up to 25 weeks, and delays in Phase III trials cost organisations an estimated £600,000 per study.

This is, at its core, a document handling problem. And it’s the underlying problem in most AI architectures.

Why bolting AI onto ungoverned content creates risk

The instinct when facing document backlogs is to move quickly: Find an AI tool, point it at your content, and see what happens. This tactic rarely ends well.

Without classification and organisation in place, AI cannot distinguish a currently approved protocol from a draft, or a document intended for an external partner from one that was never meant to leave the organisation. In a GxP environment, that creates real compliance exposure:

Unauditable AI interactions
Content shared with the wrong external partner
AI responses grounded in outdated document versions

The speed gained from rapid AI deployment is quickly consumed by the risk management that follows.

Getting the sequence right

Organisations navigating this successfully tend to follow three stages before deploying AI:

Structure your content: Centralise clinical, regulatory, quality, and commercial documents with consistent folders, metadata, naming conventions, and ownership.
Classify its sensitivity: Label content according to its confidentiality, regulatory status, version, and approved audience so the right controls can be applied automatically.
Establish governance: Define who can access, share, approve, retain, and update each type of content — with responsibility distributed across IT, legal, compliance, quality, and business teams.
Then deploy AI: Once content is organised and governed, this is how AI can safely help teams extract metadata, find information, automate workflows, and act only on trusted documents.

With that foundation in place, AI becomes genuinely useful: Automated metadata extraction compresses document review cycles from weeks to days, inspection readiness becomes a continuous state rather than a six-week scramble, and clinical teams can query their content rather than manually sifting through it.

The argument in brief

The question for biopharma leaders is not which AI model to choose but whether the content layer underneath it is sound. Know where your sensitive content is, and where it’s being shared and stored. Everything after that — AI search, metadata extraction, automated workflows — becomes dramatically more reliable.

Get the foundation right first. The AI will follow.

Health and Social Care Programme activities

techUK is helping its members navigate the complex space of digital health in the UK to ensure our NHS and social care sector is prepared for the challenges of the future. We help validate new ideas and build impactful strategies, ultimately ensuring that members are market-ready. Visit the programme page here.